Company: INDP
Filing Date: 2025-02-05
Form Type: S-3
Source: 0001493152-25-005016
Chunk: 30

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-05
Form: S-3
Chunk 30
---
writer, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the        
 registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the      
 initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part     
 of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement     
 or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective 
 date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration      
 statement or made in any such document immediately prior to such effective date.                                                         |

| (b) | That,                                                                                                                                  
 for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant     
 to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s     
 annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration  
 statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such      
 securities at that time shall be deemed to be the initial bona fide offering thereof.                                                  |
| (c) | Insofar                                                                                                                                
 as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons    
 of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the       
 Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, 
 unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of     
 expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,      
 suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,    
 the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court      
 of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities    
 Act and will be governed by